Artelo Biosciences (ARTL) Retained Earnings (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Retained Earnings of -$63.0 million for Q4 2025, down 25.69% year-over-year from -$84.8 million in Q4 2024, and down 7.08% quarter-over-quarter from -$58.8 million in Q3 2025.
Artelo Biosciences (ARTL) Retained Earnings (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Retained Earnings for 12 consecutive years, with -$63.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings fell 25.69% year-over-year to -$63.0 million; the TTM figure through Dec 2025 stood at -$63.0 million (down 25.69% YoY), while the FY2025 annual figure was -$63.0 million, down 25.69% from the prior year.
- Retained Earnings slipped to -$63.0 million in Q4 2025 per ARTL's latest filing, from -$58.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $54.6 million in Q2 2025 and bottomed at -$63.0 million in Q4 2025.
- Historically, Retained Earnings has averaged -$14.1 million across 5 years, with a median of -$17.8 million in 2021.
- On a YoY basis, Retained Earnings climbed as much as 27004.93% in 2025 and fell as far as 25766.01% in 2025.
- Artelo Biosciences' Retained Earnings stood at -$23000.0 in 2021, then slumped by 134773.91% to -$31.0 million in 2022, then surged by 99.35% to -$203000.0 in 2023, then sank by 24597.54% to -$50.1 million in 2024, then retreated by 25.69% to -$63.0 million in 2025.
- Business Quant data shows ARTL's Retained Earnings at -$63.0 million in Q4 2025, -$58.8 million in Q3 2025, and $54.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 4.38 Bn |
| 10 | Artelo Biosciences | 108,490.22 | -491,509.78 | - | -63.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.02 Mn |
| Sep 30, 2025 | -58.85 Mn |
| Jun 30, 2025 | 54.62 Mn |
| Mar 31, 2025 | -52.51 Mn |
| Dec 31, 2024 | -50.14 Mn |
| Sep 30, 2024 | 52.93 Mn |
| Jun 30, 2024 | -203,000.00 |
| Mar 31, 2024 | -203,000.00 |
| Dec 31, 2023 | -203,000.00 |
| Sep 30, 2023 | -37.24 Mn |
| Jun 30, 2023 | -201,000.00 |
| Mar 31, 2023 | -33.19 Mn |
| Dec 31, 2022 | -31.02 Mn |
| Sep 30, 2022 | -27.68 Mn |
| Jun 30, 2022 | -25.35 Mn |
| Mar 31, 2022 | -22.90 Mn |
| Nov 30, 2021 | -23,000.00 |
| Aug 31, 2021 | 18,000.00 |
| May 31, 2021 | 26.86 Mn |
| Feb 28, 2021 | -12.77 Mn |